Tadalafil (Generic) Cost in New Hampshire: 2026 Pricing, Insurance, and Savings Guide

Generic tadalafil is the FDA-approved generic version of tadalafil (brand name Cialis), a phosphodiesterase type 5 (PDE5) inhibitor prescribed for erectile dysfunction and, at a separate 5 mg daily dose, for benign prostatic hyperplasia (BPH). It is not a controlled substance. The drug itself and its approved uses are stable, well-documented facts. What is genuinely unstable, and what most "cost in [state]" pages get wrong, is the price and coverage picture: cash prices at specific pharmacies, insurer formulary tiers, Medicaid policy for a given plan year, and discount-card rates all change month to month and cannot be stated as a single reliable number for New Hampshire without checking a current, dated source at the time you fill the prescription.

The direct answer

There is no single reliable "2026 New Hampshire price" for generic tadalafil that a general article can responsibly quote. Retail cash prices for generic drugs vary by pharmacy, dose, and quantity, and they change frequently; national data sources (like GoodRx or a pharmacy's own quote line) reflect real-time pricing, while a published article does not. What can be stated with confidence is the structure of the market: tadalafil has been available generically in the United States since patent expiration made competition possible, generic entry sharply reduced average U.S. prices compared with brand-name Cialis, and cash-pay, insurance, compounded, and discount-card routes exist as distinct pricing paths with different rules. Verifying the actual number for your dose and pharmacy on the day you fill is the only reliable approach.

What tadalafil is and what it is approved for

Tadalafil is a PDE5 inhibitor. It works by blocking the enzyme that breaks down cyclic GMP in smooth muscle, which increases blood flow relevant to erectile function. Its half-life (commonly cited around 17.5 hours) is longer than sildenafil's (roughly 4 to 5 hours), which is why tadalafil is the only PDE5 inhibitor FDA-approved for both on-demand use and continuous once-daily dosing. The FDA has also approved a 5 mg daily dose specifically for BPH, and a separate tadalafil product (Adcirca) is approved for pulmonary arterial hypertension. These indications are distinct, and coverage or dosing for one does not automatically apply to another. The current FDA label is the authoritative source for approved uses, dosing, and safety information: FDA drug approval and label database.

Common side effects reported in clinical trials of tadalafil include headache, dyspepsia, back pain, muscle aches, nasal congestion, and flushing. Absolute contraindications include concurrent use of organic nitrates and the drug riociguat, because the combination can cause severe, potentially fatal drops in blood pressure. Patients on alpha-blockers for BPH or hypertension need individualized guidance from a prescriber, since combining PDE5 inhibitors with certain alpha-blockers carries an additive hypotension risk; the FDA label addresses this interaction directly and should be the reference point rather than a general summary. A small number of PDE5 inhibitor users have developed non-arteritic anterior ischemic optic neuropathy (NAION) in post-marketing reports; a causal relationship has not been established, and this remains an area of ongoing monitoring rather than a settled risk figure. Anyone with sudden vision loss, chest pain, or a priapism episode (an erection lasting more than four hours) needs urgent medical care, not a pharmacy consultation.

Daily versus on-demand dosing: a real decision, not just a cost question

Daily low-dose tadalafil (2.5 mg or 5 mg) requires a 30-tablet monthly supply and provides continuous readiness without timing an activity around the dose. On-demand dosing (10 mg or 20 mg) is taken before anticipated activity and generally requires far fewer tablets per month. Because tablet count drives cost in a cash-pay system, patients using tadalafil less than roughly once a week may find on-demand dosing cheaper, while patients with more frequent use, or with a dual ED/BPH indication, may find daily dosing more cost-effective per encounter. This is a real clinical and financial tradeoff worth raising with a prescriber, not a generic recommendation to switch: only the 5 mg daily dose is FDA-approved for BPH, and dose selection should reflect symptoms and other medications, not price alone.

New Hampshire Medicaid: what is established and what needs a current check

Federal Medicaid rules have historically allowed states to exclude drugs prescribed specifically for erectile dysfunction from Medicaid formularies, an option that emerged from the Deficit Reduction Act of 2005. Many states have exercised that option for ED indications while still covering the same drug when prescribed for BPH or pulmonary arterial hypertension under separate diagnostic codes and prior authorization. Whether New Hampshire Medicaid currently excludes tadalafil for ED, and under what exact terms it may cover it for BPH or PAH, is a state-specific, date-sensitive policy detail that should be confirmed directly with NH Medicaid or a case worker rather than assumed from this article. The general Medicaid framework and a starting point for verification is available at Medicaid.gov.

Private insurance: what to expect, not what to assume

Commercial insurers typically formulary-list generic tadalafil, often at a non-preferred generic tier with a copay higher than the cheapest generic tier, and many plans apply quantity limits (commonly a capped number of tablets per month for on-demand use) or require step therapy through a cheaper PDE5 inhibitor first. Daily dosing may need prior authorization or documentation of a BPH diagnosis to be approved without a fight. None of this can be reduced to a fixed dollar figure across "Anthem," "Cigna," or any other named carrier in New Hampshire without checking that specific member's plan document, because tiering and cost-sharing vary by employer group and plan year. High-deductible health plans are a separate consideration: if a patient has not met their deductible, the full cash price applies regardless of formulary status, which is where discount cards or compounding become more relevant.

Compounded tadalafil: legal, but with a quality tradeoff

Compounded tadalafil can be legally dispensed by a licensed 503A pharmacy under a valid, patient-specific prescription; 503A compounding is governed by the FD&C Act framework the FDA describes here: FDA compounding laws and policies. Some online platforms instead source from 503B outsourcing facilities, which operate under different oversight than 503A pharmacies compounding for an individual patient.

Compounded PDE5 inhibitor products are not FDA-approved, do not go through the bioequivalence testing that generic tablets require, and have been the subject of FDA warning letters related to potency and quality problems at specific compounding pharmacies in the past. A specific figure for how often compounded PDE5 preparations fail potency testing was present in the source material for this article but could not be verified against a checkable primary source, so it has been removed rather than repeated as fact. If cost draws you toward a compounded product, ask the pharmacy for a current certificate of analysis and confirm current New Hampshire Board of Pharmacy licensure before filling.

Telehealth prescribing in New Hampshire

Telehealth prescribing of tadalafil is broadly permitted where a valid patient-provider relationship is established, which can occur through synchronous audio-video telemedicine rather than requiring an in-person visit, since tadalafil is not a controlled substance. Federal telemedicine prescribing requirements for controlled substances (shaped by the Ryan Haight Act) do not apply to tadalafil for this reason: Ryan Haight Online Pharmacy Consumer Protection Act, 110th Congress. This does not mean every telehealth platform's pricing model is equivalent; some bundle consultation and medication into one fee, others charge a consultation fee separately and let you fill at a pharmacy of your choice, and the total cost depends on which model you use and what your pharmacy charges that week.

Veterans and VA pharmacy benefits

Veterans enrolled in VA healthcare may access tadalafil through VA pharmacy benefits at a copay set by VA policy, which changes periodically. Rather than restating a specific dollar figure that may be out of date, check the current copay tier directly: VA health care copay rates.

Evidence boundary: what is established, what is plausible, what is not established

Established: tadalafil's FDA-approved indications, mechanism, half-life relative to other PDE5 inhibitors, contraindication with nitrates, and general availability as a generic since patent expiration made competition possible.

Plausible but not something this page can confirm: the exact current NH Medicaid ED-exclusion policy, specific insurer tier placement and copay ranges for named New Hampshire carriers, and specific cash prices at named New Hampshire pharmacies. These plausibly resemble national patterns but require a direct, dated check.

Not established: any precise failure rate for compounded PDE5 products, any specific quoted statement attributed to a named guideline author, and any single "average New Hampshire price" presented as current. These have been removed or narrowed in this draft because the original source material could not be verified against a checkable primary reference.

Verification checklist: stable facts versus facts you must confirm today

Use this to separate what you can trust from a reference page versus what you must re-check before making a decision.

Stable (federal/clinical, unlikely to change quickly)

• Tadalafil is FDA-approved for ED and, at 5 mg daily, for BPH; confirm current label details at the FDA database linked above.
• Tadalafil is not a controlled substance in any U.S. jurisdiction.
• Nitrate co-administration is contraindicated due to hypotension risk.
• Generic tadalafil requires the same bioequivalence standard as any other FDA-approved generic; compounded versions do not go through that process.
• 503A compounding is legal nationally under a valid patient-specific prescription; 503B facilities operate under separate rules.

Date-sensitive (verify before you rely on it)

• Cash price at a specific New Hampshire pharmacy today, for your specific dose and quantity.
• Whether your specific NH Medicaid plan currently excludes tadalafil for ED, and what it covers for BPH or PAH with prior authorization.
• Your specific commercial plan's tier placement, copay, quantity limit, and step-therapy rule for tadalafil this plan year.
• Current discount-card or mail-order pricing (GoodRx, Cost Plus Drugs, Amazon Pharmacy, or similar), since these change frequently and are not fixed.
• Current VA pharmacy copay tier for enrolled veterans.
• Current licensure status and third-party testing practices of any compounding pharmacy you are considering.

How to verify

1. Call the specific pharmacy and ask for today's cash price for your exact dose and tablet count.
2. Log into your insurance member portal or call member services and ask for the tadalafil tier, copay, and any prior authorization or step-therapy requirement.
3. Contact NH Medicaid directly, or your Medicaid managed-care plan, for the current ED-drug exclusion policy and any BPH/PAH coverage pathway.
4. Ask a compounding pharmacy for its current New Hampshire Board of Pharmacy license number and a recent certificate of analysis before filling.

Questions readers actually ask

References

• U.S. Food and Drug Administration. Tadalafil approval history and prescribing information: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
• U.S. Food and Drug Administration. Human drug compounding laws and policies: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
• Medicaid.gov: https://www.medicaid.gov/
• U.S. Department of Veterans Affairs. Health care copay rates: https://www.va.gov/health-care/copay-rates/
• 110th Congress. Ryan Haight Online Pharmacy Consumer Protection Act of 2008: https://www.congress.gov/bill/110th-congress/house-bill/6353

Note for reviewers: the original draft's PubMed citations, quoted statements attributed to named guideline authors, and several precise New Hampshire dollar figures and percentages could not be verified against a checkable primary source in this review pass and have been removed or replaced with narrowed, general statements. These should be re-sourced or restored with correct citations during medical review before publication. This article has not yet undergone qualified medical review.